Cargando…
Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives...
Autores principales: | Elfassy, Caroline, Wagner, Lisa, Higgins, Johanne, Montpetit, Kathleen, Snider, Laurie, Dahan-Oliel, Noémi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408044/ https://www.ncbi.nlm.nih.gov/pubmed/37553603 http://dx.doi.org/10.1186/s40900-023-00479-6 |
Ejemplares similares
-
Effectiveness and Safety of Botulinum Toxin Type A in Children with Musculoskeletal Conditions: What Is the Current State of Evidence?
por: Dahan-Oliel, Noémi, et al.
Publicado: (2012) -
A Portrait of the Rights of Children with Disabilities in Nigeria: A Policy Review
por: Elekanachi, Rose Uzoma, et al.
Publicado: (2023) -
Functional Gains in Children With Spastic Hemiplegia Following a Tendon Achilles Lengthening Using Computerized Adaptive Testing—A Pilot Study
por: Saleh, Eli, et al.
Publicado: (2018) -
Epidemiology of musculoskeletal upper extremity ambulatory surgery in the United States
por: Jain, Nitin B, et al.
Publicado: (2014) -
A Telerehabilitation Intervention for Youths With Arthrogryposis Multiplex Congenita: Protocol for a Pilot Study
por: Gagnon, Marianne, et al.
Publicado: (2020)